期刊文献+

4,6-二芳基-2-氨基嘧啶类衍生物的合成与生物活性 被引量:2

Synthesis and Biological Activities of 4,6-Diaryl-2-aminopyrimidine Derivatives
下载PDF
导出
摘要 合成并表征了5种4,6-二芳基-2-氨基嘧啶类化合物。测试了它们对大肠肝菌甲硫酰胺肽酶(EcMetAP)的抑制作用及对CXCR4受体的拮抗作用。发现5种化合物均对EcMetAP酶活有抑制作用,除化合物2外均对CXCR4受体有拮抗作用。利用FieldTemplater和FieldAlign软件对化合物1~5的上述活性构效关系进行了分析,初步认为化合物的嘧啶环3位N原子及4位取代苯环上若引入给电子基团,可增强这类化合物的EcMetAP酶抑制活性;在嘧啶环2位引入负电性较强的基团取代,改造2个苯环和嘧啶环的4、5、6位C原子的结构可增强其CXCR4受体拮抗活性。 Five kinds of 4,6-diaryl-2-aminopyrimidine derivatives were synthesized and characterized by IR,MS and 1H NMR.The Escherichia coli methionine aminopeptidase(EcMetAP) inhibit-activities and the CXCR4 receptor antogonists activities of the five compounds were determined.The results show that all the five compounds have the EcMetAP inhibit-activities,and they also have CXCR4 receptor antogonists activities except the compound 2.The structure-activity relationships were studied by the FieldTemplater and FieldAlign software through molecular field analysis.The results show that the pharmacophore could be 3-N atom and 4,6-bencycles used as the EcMetAP inhibitor,and the EcMetAP inhibit-activities could be increased by addition of electron-donating groups at 6-benzyl.It also shows that the pharmacophore could be 2-C atom and 4,6-bencycles used as the CXCR4 receptor antogonists.The CXCR4 receptor antogonists could be increased by addition of electron-donating substituent at 2-C.
出处 《应用化学》 CAS CSCD 北大核心 2011年第2期209-213,共5页 Chinese Journal of Applied Chemistry
基金 国家自然科学青年基金(20901067) 浙江省自然科学基金(Y4080342)资助项目
关键词 嘧啶 合成 大肠杆菌甲硫酰胺肽酶 CXCR4 构效关系 pyrimidine synthesis EcMetAP CXCR4 structure-activity relationship
  • 相关文献

参考文献14

  • 1Agarwal A, Srivastava K, Purib S K, et al. Antimalarial Activity and Synthesis of New Trisubstituted Pyrimidines [ J ]. Bioorg Med Chem Lett, 2005,15 ( 12 ) : 3130-3132.
  • 2Boehm J C,Adams J L. New Inhibitors of p38 Kinase[J]. Expert Opin Ther Patents ,2000,10( 1 ) :25-37.
  • 3Pargellis C A,Tong L,Churchill L,et al. Inhibition of p38 MAP Kinase by Utilizing a Novel Allosteric Binding Site[ J]. Nat Struct Biol,2002,9 (4) : 268-272.
  • 4Lee M R, Dominguez C. MAP Kinase p38Inhibitors: Clinical Results and an Intimate look at Their Interactions with p38 Protein [ J ]. Curr Med Chem 1,2005,12 (25) :2979-2994.
  • 5Bolo's J. Structure - Activity Relationships of p38 Mitogen-Activated Protein Kinase Inhibitors [ J ]. Mini-Rev Med Chem [ J] ,2005,5(9) :857-868.
  • 6Rich S, Reinhard H, Hilmar M. Hilmar M. Phenykpyrazolcarboxylic Acid Derivative Preparation. Ger Often DE 3633840 [ P], 19886-10-04.
  • 7Peter B, Guenter S, Paul G. Transparent Greenish Yellow Pyrazolone Pigment. WO 2002048266 [ P], 2002-10-24.
  • 8Agarwal A, Srivastava K, Purib S K, et al. Synthesis of 2, d, 6-Trisubstituted Pyrimidines as Antimalarial Agents [ J]. Bioorg Med Chem,2005,13( 15 ) :4645-4650.
  • 9Tran T Dao,Park H,KimH P,et al. Inhibitory Activity of Prostaglandin E2 Production by the Synthetic 2'-Hydroxychalcone Analogues: Synthesis and SAR Study [ J ]. Bioorg Med Chem Lett,2009,19 (6) : 1650-1653.
  • 10Stirrett K L, Ferreras J A ,Jayaprakash V, et al. Small Molecules with Structural Similarities to Siderophores as Novel Antimicrobials Against Mycobacterium Tuberculosis and Yersinia Pestis[ J ]. Bioorg Med Chem Lett ,2008,18 (8) :2662- 2668.

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部